You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
関節リウマチを主な適用疾患とするバイオ医薬品における有害事象プロファイルの比較
|
|---|---|
| Published in |
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, January 2017
|
| DOI | 10.3820/jjpe.21.63 |
| Authors |
小林 哲, 村山 一茂, 太田 悠葵, 川崎 ナナ, 豊島 聰, 石井 明子 |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2017.
All research outputs
#14,873,694
of 24,396,012 outputs
Outputs from Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
#18
of 40 outputs
Outputs of similar age
#228,248
of 429,227 outputs
Outputs of similar age from Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
#2
of 2 outputs
Altmetric has tracked 24,396,012 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 40 research outputs from this source. They receive a mean Attention Score of 4.1. This one scored the same or higher as 22 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,227 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.